Efalizumab (brand name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by …

2024年10月29日 · Raptiva is used to treat plaque psoriasis (raised, silvery flaking of the skin) in adults. Learn about side effects, interactions and indications.

Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market.

RAPTIVA increases the risk for PML, a rapidly progressive viral infection of the central nervous system that has no known treatment and that leads to death or severe disability.

Genentech’s decision to withdraw is based on the finding of an association with the use of Raptiva and an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually...

Learn about the side effects of Raptiva (efalizumab), from common to rare, for consumers and healthcare professionals.

What Is Raptiva? Raptiva (efalizumab) is an immunosuppressive medication used to treat plaque psoriasis (raised, silvery flaking of the skin) in adults. The brand name Raptiva is discontinued, …

2023年12月12日 · Efalizumab is a synthetic (man-made) antibody that is used for the treatment of psoriasis. Psoriasis is a disease of the skin in which the cells of the skin reproduce more …

2005年6月13日 · Efalizumab is a monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis. Humanized IgG1 kappa isotype monoclonal antibody that binds to …

2009年4月9日 · Efalizumab is a genetically modified form of mouse protein that is directed at blocking T cell activation and proliferation by binding to CD11a receptors on T cells. This stops …